A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2006
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264377 Chemically modified novel erythropoietin stimulating protein compositions and methods
11/23/2006	US20060263447 Treating pulmonary disorders with gaseous agent causing repletion of GSNO
11/23/2006	US20060263359 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/23/2006	US20060263347 Lyophilizing an aqueous mixture of a fibrinolytic metalloproteinase, a zinc stabilizer and optionally a bulking agent, in a citric acid or a water soluble citric acid salt buffer and reconstituing said lyophilized composition
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2609080A1 Medicament made from laminarine or oligolaminarines for treatment of septicemia and septic shock
11/22/2006	EP1724339A1 Gene regulation therapy involving ferritin
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724277A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/22/2006	EP1724269A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1722802A1 A medical solution, a method for producing said medical solution and use thereof
11/22/2006	EP1722801A1 Use of enhanced water to improve blood sugar management
11/22/2006	EP1722800A1 A medical solution, a method for producing said medical solution and use thereof
11/22/2006	EP1635817B1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
11/22/2006	EP1558080A4 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
11/22/2006	EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1420778B1 Use of mek inhibitors for treating virus induced hemorrhagic shock or fever
11/22/2006	EP1298132B1 Hydropyridine derivative acid addition salts
11/22/2006	EP1282444B1 Antithrombotic agents
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1864744A Pharmaceutical preparation containing urate oxidase
11/22/2006	CN1864737A Powder dedicated for treating leukemia and preparation method thereof
11/22/2006	CN1864731A Anti-thrombosis blood fat-reducing blood pressure-decreasing oral liquid
11/22/2006	CN1864716A Prescription of collateral-dredging capsule with astragalus root and earthworm and preparation method thereof
11/22/2006	CN1864696A New formulation
11/22/2006	CN1864677A An anti-thrombus anti-restenosis composite medicine coated on eluting stent
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285359C Health food of Chinese traditional medicine for promoting hematopoiesis and preparation method
11/22/2006	CN1285337C Application of Japanese raspberry saponin in the treatment of cerebral ischemia disease
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138379 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138143 Coated preparation soluble in the lower digestive tract
11/21/2006	US7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
11/21/2006	US7138114 Pharmaceutical compositions of fibrinolytic agent
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/16/2006	WO2006121249A1 Cilostazol composite having increasing solubility, process for preparation and use thereof
11/16/2006	WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	WO2006120160A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
11/16/2006	WO2006081517A3 Embolization using poly-4-hydroxybutyrate particles
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257474 anti-thrombocytic agent and an HMG-CoA reductase inhibitor in an amount sufficient to treat chronic glomerular nephritis wherein the anti-thrombocytic agent is selected from dilazep, dipyridamole and or salts thereof and the HMG-CoA reductase inhibitor is pitavastatin
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006	DE102005023155A1 Albuminlösung Albumin solution
11/16/2006	CA2811995A1 Use of histones to treat thrombocytopenia
11/16/2006	CA2608019A1 Use of histones to treat thrombocytopenia
11/16/2006	CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721606A2 Buffered compositions for dialysis
11/15/2006	EP1721533A1 Composition for inhibiting thrombosis
11/15/2006	EP1720889A1 Sulfated oligosaccharide derivatives
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720570A2 Treatment of dengue hemorrhagic fever
11/15/2006	EP1495111A4 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
11/15/2006	EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1335919B1 Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1272197B1 Combination of lecithin with ascorbic acid
11/15/2006	EP1198560B1 Mammalian adhesion protease
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863798A 2,4-dioxo-3-quinazolinylaryl sulfonylureas
11/15/2006	CN1863783A Compounds having thrombopoietin receptor agonism
11/15/2006	CN1863560A Fibrinogen targetting microparticles for promoting haemostasie
11/15/2006	CN1861146A Compound soft capsule 'Xueshuantong' for treating thrombus disease and its prepn. method
11/15/2006	CN1861099A 蛇油软胶囊 Snake Oil Soft Capsule
11/15/2006	CN1861097A Deer blood wine
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861070A Use of tanshinone type compounds for preparing medicines to treat angiitis

1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 671